511 related articles for article (PubMed ID: 25499552)
1. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Huebner F; Zeuzem S; Korf HW; Vogl TJ; Rittmeyer C; Terfort A; Piiper A; Gelperina S; Kreuter J
Eur J Pharm Biopharm; 2014 May; 87(1):132-41. PubMed ID: 24365328
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
[TBL] [Abstract][Full Text] [Related]
4. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
5. Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging.
Korkusuz H; Ulbrich K; Bihrer V; Welzel K; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Korkusuz Y; Kromen W; Hammerstingl R; Haupenthal J; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging; 2012; 11(4):272-9. PubMed ID: 22954143
[TBL] [Abstract][Full Text] [Related]
6. Transferrin-coated gadolinium nanoparticles as MRI contrast agent.
Korkusuz H; Ulbrich K; Welzel K; Koeberle V; Watcharin W; Bahr U; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Kromen W; Hammerstingl R; Haupenthal J; Gruenwald F; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging Biol; 2013 Apr; 15(2):148-54. PubMed ID: 22811020
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
[TBL] [Abstract][Full Text] [Related]
9. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.
Park YS; Lee CH; Kim BH; Lee J; Choi JW; Kim KA; Ahn JH; Park CM
Magn Reson Imaging; 2013 Sep; 31(7):1137-42. PubMed ID: 23688409
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
11. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
13. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
14. [A case of hepatocellular carcinoma which could be diagnosed with Gd-EOB-DTPA enhanced MRI].
Ota H; Mikami K; Nagase A; Nagase H; Mukai R; Okada K; Ide Y; Maruyama K; Murata K; Yokouchi H; Tamai M; Kinuta M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2386-8. PubMed ID: 20037431
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.
Korkusuz H; Knau L; Kromen W; Huebner F; Hammerstingl R; Lindemayr S; Bihrer V; Piiper A; Vogl TJ
Cancer Imaging; 2012 Mar; 12(1):72-8. PubMed ID: 22418445
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.
Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Ushijima Y; Takayama Y; Shirabe K; Fujita N; Kubo Y; Hirakawa M; Honda H
J Gastroenterol Hepatol; 2014 Mar; 29(3):561-7. PubMed ID: 24219648
[TBL] [Abstract][Full Text] [Related]
18. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
Kuo YT; Chen CY; Liu GC; Wang YM
PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
[TBL] [Abstract][Full Text] [Related]
19. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
20. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]